Figures & data
Table 1. Distribution of all-cause and diabetes-related costs among type 2 diabetes patients with oral hypoglycemic agent and lab test usage.
Table 2. Characteristics of study population: comparison high all-cause cost cohort vs lower all-cause cost cohort.
Table 3. All-cause and diabetes-related high cost drivers among type 2 diabetes patients receiving OHAs.
Table 4. Inpatient admission related to a complication of diabetes, breakdown by type of admission.